Biomimetic matrix fabricated by LMP-1 gene-transduced MC3T3-E1 cells for bone regeneration. (14th November 2017)

• Record Type: Journal Article
• Authors: Ma, Junxuan; Guo, Wei; Gao, Manman; Huang, Baoding; Qi, Qihua; Ling, Zemin; Chen, Yan; Hu, Hao; Zhou, Hailian; Yu, Fei; Chen, Ke; Richards, Geoff; Lin, Jianjing; Zhou, Zhiyu; Xiao, Deming; Zou, Xuenong
• Is Part Of: Biofabrication. Volume 9:Number 4(2017)
• Publication Date: 2017-11-14
• Subjects: bone regeneration -- extracellular matrix -- lentiviral vector -- LIM mineralization protein-1 -- critical-sized bone defect -- growth factor; Biomedical engineering -- Periodicals; Tissue engineering -- Periodicals; Biomedical materials -- Microstructure -- Periodicals; Bioengineering -- Periodicals; 610.28
• DOI: 10.1088/1758-5090/aa8dd1
• Languages: English
• ISSNs: 1758-5082

Abstract

Abstract: Bone healing is regulated by multiple microenvironmental signals provided by the extracellular matrix (ECM). This study aimed to mimic the native osteoinductive microenvironment by developing an ECM using gene-transduced cells. The LIM mineralization protein-1 (LMP-1) gene was transferred to murine pre-osteoblast cells (MC3T3-E1) using lentiviral vectors. Western blotting assay indicated that the MC3T3-E1 cells expressed an increased level of bone morphologic protein-2, -4 and -7 (BMP-2, -4 and -7) after LMP-1 gene transduction. The transduced cells were then seeded into calcined bovine bone scaffolds and cultured for 7, 14, and 21 days to construct ECMs on the scaffolds. The ECM–scaffold composites were then decellularized using the freeze-drying method. Scaffolds without ECM deposition were used as controls. The composites and controls were implanted into critical-sized bone defects created in the distal femurs of New Zealand rabbits. Twelve weeks after the surgery, both microcomputed tomography and histologic results indicated that the 7-day-cell-modified ECM–scaffold composites induced bone regeneration with significantly larger volume, trabecular thickness and connectivity than the controls. However, the 14- and 21-day-cell-modified ECM–scaffold composites triggered sustained inflammation response even at 12 weeks after the surgery and showed less bone ingrowth and integration than their 7-day-cell-modified counterparts. In conclusion, these results highlight the viable gene transfer techniques for manipulating cells in a constructed microenvironment of ECM for bone regeneration. However, the unresolved inflammation relating to the duration of ECM modification needs to be considered.